State of New Jersey Common Pension Fund D’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$597K Sell
71,364
-9,973
-12% -$90.9K ﹤0.01% 1609
2026
Q1
$733K Sell
81,337
-112
-0.1% -$1.77K ﹤0.01% 1424
2025
Q4
$1.49M Sell
81,449
-42,941
-35% -$724K 0.01% 1375
2025
Q3
$1.82M Buy
124,390
+30,965
+33% +$531K 0.01% 1399
2025
Q2
$1.7M Sell
93,425
-31,221
-25% -$637K 0.01% 1404
2025
Q1
$2.47M Buy
124,646
+22,893
+22% +$396K 0.01% 792
2024
Q4
$1.75M Sell
101,753
-11,854
-10% -$223K 0.01% 1477
2024
Q3
$2.27M Sell
113,607
-84,249
-43% -$1.31M 0.01% 937
2024
Q2
$2.21M Buy
+197,856
New +$1.66M 0.01% 891

Other funds holding ADMA

State of New Jersey Common Pension Fund D's ADMA Position: Q2 2026 in Review

State of New Jersey Common Pension Fund D reduced its ADMA Biologics (ADMA) stake by 12% in Q2 2026, selling an estimated $90.9K and leaving 71,364 shares worth $597K. The position accounts for ﹤0.01% of the portfolio, ranked #1609.

State of New Jersey Common Pension Fund D first reported a position in ADMA in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.47M in Q1 2025. 160 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • State of New Jersey Common Pension Fund D held 71,364 shares of ADMA Biologics worth $597K as of Q2 2026.
  • State of New Jersey Common Pension Fund D sold 9,973 ADMA Biologics shares in Q2 2026, an estimated $90.9K.
  • ADMA Biologics made up ﹤0.01% of State of New Jersey Common Pension Fund D's portfolio in Q2 2026, its #1609 holding.
  • State of New Jersey Common Pension Fund D first reported a position in ADMA Biologics in Q2 2024 and has held it in 9 quarters since.
  • State of New Jersey Common Pension Fund D's ADMA Biologics position peaked at $2.47M in Q1 2025.
  • 160 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q2 2026, filed 4 Aug 2026.